Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Novartis AG

Novartis AG is reportedly considering a $XXX million manufacturing plant in Denton, Texas, while also facing scrutiny over potential US price cuts and tariffs.

### About Novartis AG
Novartis AG is a global pharmaceutical company.  

### Insights
- Novartis AG Price hit a 52-Week high of $XXXXXX for the hour
- Novartis AG Price hit an all time of $XXXXXX for the hour

### Price: $
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/close.tsv)  
The price is experiencing volatility due to positive news on Kesimpta and R&D investments, but also uncertainty surrounding US price cuts and potential tariffs, leading to an hourly all-time high.  

1-Year High: $XXXXXX on 2025-12-03  
1-Year Low: $XX on 2025-04-09  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/alt_rank.tsv)  
Novartis AG is currently AltRank #199 based on combined combined social and market metrics
Daily Average: XXX  
1-Year High: XXX on 2025-04-01  
1-Year Low: X on 2025-11-27  
  
  
### Galaxy Score: XX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/galaxy_score.tsv)  
Current Value: XX  
Daily Average: XX  
1-Year High: XX on 2025-03-07  
1-Year Low: XX on 2024-12-28  
  
  
### Engagements: XXXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/interactions.tsv)  
Current Value: XXXXXXX  
Daily Average: XXXXXXX  
X Week: XXXXXXX -XX%  
X Month: XXXXXXXXXX +112%  
X Months: XXXXXXXXXX +166%  
X Year: XXXXXXXXXX +184%  
1-Year High: XXXXXXXXX on 2025-11-27  
1-Year Low: XXXXXX on 2025-01-07  

Engagements by network (24h):
News: XXXXX
Reddit: XXXXX
TikTok: XXXXXX
X: XXXXXX
YouTube: XXXXXX

  
  
### Mentions: XXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/posts_active.tsv)  
Current Value: XXX  
Daily Average: XXX  
X Week: XXXXX -XXXX%  
X Month: XXXXX -XX%  
X Months: XXXXXX +34%  
X Year: XXXXXX +195%  
1-Year High: XXXXX on 2025-10-27  
1-Year Low: XXX on 2024-12-25  

Mentions by network (24h):
News: XX
Reddit: XXX
TikTok: XXX
X: XXXXX
YouTube: XXX

  
  
### Creators: XXX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Novartis AG in the last XX hours which is down X% from XXX in the previous XX hours
Daily Average: XXX  
X Week: XXX -XXXX%  
X Month: XXXXX -XX%  
X Months: XXXXX +27%  
X Year: XXXXXX +191%  
1-Year High: XXX on 2025-10-27  
1-Year Low: XXX on 2024-12-25  

The most influential creators that mention Novartis AG in the last XX hours

| Creator                                                 | Rank | Followers   | Posts | Engagements |
| -------                                                 | ---- | ---------   | ----- | ----------- |
| [@StockMKTNewz](/creator/twitter/StockMKTNewz)          | X    | XXXXXXX     | X     | XXXXXX      |
| [@stats_feed](/creator/twitter/stats_feed)              | X    | XXXXXXXXX   | X     | XXXXX       |
| [@Darwin_Knows](/creator/twitter/Darwin_Knows)          | X    | XXX         | XX    | XXXXX       |
| [@ThePlayersTV](/creator/twitter/ThePlayersTV)          | X    | XXXXX       | X     | XXX         |
| [@StockTickerZone](/creator/twitter/StockTickerZone)    | X    | XXXXX       | X     | XXX         |
| [@msviewsandnews](/creator/youtube/msviewsandnews)      | X    | XXXXXX      | X     | XXX         |
| [@novartis](/creator/youtube/novartis)                  | X    | XXXXXX      | X     | XXX         |
| [@bloombergbusiness](/creator/tiktok/bloombergbusiness) | X    | XXXXXXX     | X     | XXX         |
| [@SeekingAlpha](/creator/twitter/SeekingAlpha)          | X    | XXXXXXXXXXX | X     | XXX         |
| [@BigPharmaSuxcom](/creator/twitter/BigPharmaSuxcom)    | XX   | X           | XX    | XXX         |

[View More](/list/creators/$novnsw/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% +4%  
X Month: XX% -X%  
X Months: XX% +4%  
X Year: XX% +3%  
1-Year High: XX% on 2025-10-26  
1-Year Low: XX% on 2025-11-26  

Most Supportive Themes:
- Kesimpta Efficacy: (35%) Positive data supporting the benefits of Kesimpta in relapsing multiple sclerosis (RMS) is being shared across multiple social networks.
- R&D and Acquisitions: (20%) Mentions of Novartis's investments in R&D and acquisitions, such as Regulus Therapeutics, are generating positive sentiment.
- Access to Medicines: (15%) Positive sentiment around Novartis's efforts to provide access to medicines, particularly in collaboration with organizations like the UICC.
  
Most Critical Themes:
- US Price Cuts and Tariffs: (10%) Discussions around potential price cuts in the US market, driven by CEO comments and potential tariff impacts, are generating some critical sentiment.
- Vymada Patent Revocation: (5%) The revocation of Novartis's patent for Vymada in India is a critical point.
  
  
  
### Market Cap: $undefined
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$novnsw/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$novnsw/time-series/market_cap.tsv)  
Current Value: $undefined  
Daily Average: $XXXXXXXXXXXXXXX  
1-Year High: $XXXXXXXXXXXXXXX on 2025-02-25  
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-20  

### Top Novartis AG News
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Pharmaceutical giant eyeing Denton for $XXX million manufacturing plant"  
[News Link](https://www.dallasnews.com/business/real-estate/2025/12/15/pharmaceutical-giant-eyeing-denton-for-280-million-manufacturing-plant/) [@dallasnews](/creator/x/dallasnews) 2025-12-15T22:00Z 228.6M followers, 3835 engagements


"Novartis pharma plant incentives up for vote in Denton - Dallas Business Journal"  
[News Link](https://www.bizjournals.com/dallas/news/2025/12/15/novartis-incentives-hillwood-landmark.html) [@bizjournals](/creator/x/bizjournals) 2025-12-15T13:20Z 228.6M followers, XXX engagements


"Notable healthcare headlines for the week: CVS Eli Lilly and Novartis in focus Seeking Alpha"  
[News Link](https://seekingalpha.com/news/4531209-notable-healthcare-headlines-for-the-week-cvs-eli-lilly-and-novartis-in-focus) [@SeekingAlpha](/creator/x/SeekingAlpha) 2025-12-14T16:10Z 228.6M followers, 2077 engagements



### Top Novartis AG Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"All these stocks hit new XX WEEK HIGHS at some point today Tesla $TSLA Ford $F TKO Group $TKO Delta Airlines $DAL General Motors $GM Dollar General $DG Southwest $LUV Dollar Tree $DLTR Aercap $AER Chubb $CB $CRH Expedia $EXPE Gildan $GIL Hartfird $HIG Magna $MGA Novartis $NVS Ross Stores $ROST UBS Group $UBS"  
[X Link](https://x.com/Bourbon7749/status/2001093001955958888) [@Bourbon7749](/creator/x/Bourbon7749) 2025-12-17T00:52Z XXX followers, XX engagements


"@scott_wysocki For context the article mentions X drugs for Adult B-cell ALL that $AUTL competes against. 2026 projected sales for each (B-ALL): - Novartis Kymriah: $50M - Gilead/Kite Tecartus: $150-300M - Amgen Blincyto: $2.1-2.3B - Pfizer's Besponsa: $200-350M - Incyte Iclusig: $50-125M"  
[X Link](https://x.com/Corona_N_Lyme/status/2001074885116731868) [@Corona_N_Lyme](/creator/x/Corona_N_Lyme) 2025-12-16T23:40Z 1844 followers, XX engagements


"GO2 Living Room December 16th 2025 - Reflecting on Our Year & Holiday Celebration"  
[YouTube Link](https://youtube.com/watch?v=tKqifNrotHA) [@go2forlungcancer](/creator/youtube/go2forlungcancer) 2025-12-16T23:02Z 4370 followers, XX engagements


"Hipra ficha a exdirectivos de Werfen y Novartis como consejeros independientes"  
[X Link](https://x.com/exp_empresas/status/2001048285063041429) [@exp_empresas](/creator/x/exp_empresas) 2025-12-16T21:54Z 18.5K followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Novartis AG

Novartis AG is reportedly considering a $XXX million manufacturing plant in Denton, Texas, while also facing scrutiny over potential US price cuts and tariffs.

About Novartis AG

Novartis AG is a global pharmaceutical company.

Insights

  • Novartis AG Price hit a 52-Week high of $XXXXXX for the hour
  • Novartis AG Price hit an all time of $XXXXXX for the hour

Price: $

Price Line Chart
Price 24-Hour Time-Series Raw Data
The price is experiencing volatility due to positive news on Kesimpta and R&D investments, but also uncertainty surrounding US price cuts and potential tariffs, leading to an hourly all-time high.

1-Year High: $XXXXXX on 2025-12-03
1-Year Low: $XX on 2025-04-09

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Novartis AG is currently AltRank #199 based on combined combined social and market metrics Daily Average: XXX
1-Year High: XXX on 2025-04-01
1-Year Low: X on 2025-11-27

Galaxy Score: XX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-03-07
1-Year Low: XX on 2024-12-28

Engagements: XXXXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXX -XX%
X Month: XXXXXXXXXX +112%
X Months: XXXXXXXXXX +166%
X Year: XXXXXXXXXX +184%
1-Year High: XXXXXXXXX on 2025-11-27
1-Year Low: XXXXXX on 2025-01-07

Engagements by network (24h): News: XXXXX Reddit: XXXXX TikTok: XXXXXX X: XXXXXX YouTube: XXXXXX

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXXXX -XXXX%
X Month: XXXXX -XX%
X Months: XXXXXX +34%
X Year: XXXXXX +195%
1-Year High: XXXXX on 2025-10-27
1-Year Low: XXX on 2024-12-25

Mentions by network (24h): News: XX Reddit: XXX TikTok: XXX X: XXXXX YouTube: XXX

Creators: XXX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Novartis AG in the last XX hours which is down X% from XXX in the previous XX hours Daily Average: XXX
X Week: XXX -XXXX%
X Month: XXXXX -XX%
X Months: XXXXX +27%
X Year: XXXXXX +191%
1-Year High: XXX on 2025-10-27
1-Year Low: XXX on 2024-12-25

The most influential creators that mention Novartis AG in the last XX hours

Creator Rank Followers Posts Engagements
@StockMKTNewz X XXXXXXX X XXXXXX
@stats_feed X XXXXXXXXX X XXXXX
@Darwin_Knows X XXX XX XXXXX
@ThePlayersTV X XXXXX X XXX
@StockTickerZone X XXXXX X XXX
@msviewsandnews X XXXXXX X XXX
@novartis X XXXXXX X XXX
@bloombergbusiness X XXXXXXX X XXX
@SeekingAlpha X XXXXXXXXXXX X XXX
@BigPharmaSuxcom XX X XX XXX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +4%
X Month: XX% -X%
X Months: XX% +4%
X Year: XX% +3%
1-Year High: XX% on 2025-10-26
1-Year Low: XX% on 2025-11-26

Most Supportive Themes:

  • Kesimpta Efficacy: (35%) Positive data supporting the benefits of Kesimpta in relapsing multiple sclerosis (RMS) is being shared across multiple social networks.
  • R&D and Acquisitions: (20%) Mentions of Novartis's investments in R&D and acquisitions, such as Regulus Therapeutics, are generating positive sentiment.
  • Access to Medicines: (15%) Positive sentiment around Novartis's efforts to provide access to medicines, particularly in collaboration with organizations like the UICC.

Most Critical Themes:

  • US Price Cuts and Tariffs: (10%) Discussions around potential price cuts in the US market, driven by CEO comments and potential tariff impacts, are generating some critical sentiment.
  • Vymada Patent Revocation: (5%) The revocation of Novartis's patent for Vymada in India is a critical point.

Market Cap: $undefined

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2025-02-25
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-20

Top Novartis AG News

Top news links shared on social in the last XX hours

Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.

"Pharmaceutical giant eyeing Denton for $XXX million manufacturing plant"
News Link @dallasnews 2025-12-15T22:00Z 228.6M followers, 3835 engagements

"Novartis pharma plant incentives up for vote in Denton - Dallas Business Journal"
News Link @bizjournals 2025-12-15T13:20Z 228.6M followers, XXX engagements

"Notable healthcare headlines for the week: CVS Eli Lilly and Novartis in focus Seeking Alpha"
News Link @SeekingAlpha 2025-12-14T16:10Z 228.6M followers, 2077 engagements

Top Novartis AG Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"All these stocks hit new XX WEEK HIGHS at some point today Tesla $TSLA Ford $F TKO Group $TKO Delta Airlines $DAL General Motors $GM Dollar General $DG Southwest $LUV Dollar Tree $DLTR Aercap $AER Chubb $CB $CRH Expedia $EXPE Gildan $GIL Hartfird $HIG Magna $MGA Novartis $NVS Ross Stores $ROST UBS Group $UBS"
X Link @Bourbon7749 2025-12-17T00:52Z XXX followers, XX engagements

"@scott_wysocki For context the article mentions X drugs for Adult B-cell ALL that $AUTL competes against. 2026 projected sales for each (B-ALL): - Novartis Kymriah: $50M - Gilead/Kite Tecartus: $150-300M - Amgen Blincyto: $2.1-2.3B - Pfizer's Besponsa: $200-350M - Incyte Iclusig: $50-125M"
X Link @Corona_N_Lyme 2025-12-16T23:40Z 1844 followers, XX engagements

"GO2 Living Room December 16th 2025 - Reflecting on Our Year & Holiday Celebration"
YouTube Link @go2forlungcancer 2025-12-16T23:02Z 4370 followers, XX engagements

"Hipra ficha a exdirectivos de Werfen y Novartis como consejeros independientes"
X Link @exp_empresas 2025-12-16T21:54Z 18.5K followers, XX engagements

Novartis AG
/topic/$novnsw